(Q45903959)

17 December 2017

title

Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer's disease with PS1 mutations. (English)

1 reference

17 December 2017

0 references

0 references

0 references

Masaki Ikeda

1

1 reference

17 December 2017

Kimie Yonemura

2

1 reference

17 December 2017

Satoko Kakuda

3

1 reference

17 December 2017

Yuichi Tashiro

4

1 reference

17 December 2017

Yukio Fujita

5

1 reference

17 December 2017

Eriko Takai

6

1 reference

17 December 2017

Yukiko Hashimoto

7

1 reference

17 December 2017

Kouki Makioka

8

1 reference

17 December 2017

Natsumi Furuta

9

1 reference

17 December 2017

Koichi Ishiguro

10

1 reference

17 December 2017

Risa Maruki

11

1 reference

17 December 2017

Jun'ichi Yoshida

12

1 reference

17 December 2017

Osamu Miyaguchi

13

1 reference

17 December 2017

Tamao Tsukie

14

1 reference

17 December 2017

Ryouzou Kuwano

15

1 reference

17 December 2017

Tsuneo Yamazaki

16

1 reference

17 December 2017

Haruyasu Yamaguchi

17

1 reference

17 December 2017

Masakuni Amari

18

1 reference

17 December 2017

Masamitsu Takatama

19

1 reference

17 December 2017

Yasuo Harigaya

20

1 reference

17 December 2017

Koichi Okamoto

21

1 reference

17 December 2017

publication date

2 May 2013

1 reference

17 December 2017

published in

Amyloid

1 reference

17 December 2017

volume

20

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

107-112

1 reference

17 December 2017

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

The clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Does this patient have dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Encephalopathy with amyloid angiopathy and numerous amyloid plaques with low levels of CSF Aβ1-40/Aβ1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Altered γ-secretase activity in mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Longitudinal changes of CSF biomarkers in memory clinic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.790810

10.3109/13506129.2013.790810

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017